Thursday, November 17, 2016 11:15:20 AM
STOCK PRICE VALUATION: In addition, since Novus is a publicly traded
company insurance entities trade higher, around 20 times multiple and the
stock price is valued on a “Book Value” basis. By monetizing the Letter of
Credit we can project the stock price at $2.73 per share giving the company a
Market Capitalization of $300 million. During year 1.
Recent NDEV News
- Branded Legacy and Novus Partner to Develop Plant-Based Meds for Health Plans • InvestorsHub NewsWire • 09/12/2023 11:30:00 AM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM